On October 28, 2025, Co-Diagnostics, Inc. announced a registered direct offering of 12,002,272 shares at $0.55 each and pre-funded warrants for 725,000 shares, aiming to raise approximately $7 million for working capital. This significantly impacts capital structure and is considered a significant event.